Search results

Didn't feel like going deeper into the evidence because the included populations were so diverse and dissimilar to ME/CFS. Also got the impression that the reviewers didn't care much about quality of evidence. Only briefly scanned the studies but of the 25 included I don't think there's one...

Made this thread on the review: 1) A new review on Long Covid recommends 'exercise training' but it's based on low-quality trials with high risk of bias and problematic inclusion criteria. Some didn't even focus on Long Covid patients, just people who survived COVID-19. 2) The review included...

Not sure if that is the CFS prevalence or just the prevalence of 'four or more additional symptoms.'

In that case it might be quite important. I wonder if we should interpret the likelihood of possible genes in light of this MAGMA analysis: those that are not expressed in the brain might be less likely to be a relevant gene compared to those who are highly expressed in the brain (Figure 4 In...

I think in the DecodeME webinar just now Sonya said that they had 9 requests from other researchers to access the DecodeME data.

Thanks, will try to take a closer look at this. So it's like they used all possible genes but weighed them by how much the SNP signal from the GWAS points to them? That would make more sense and make there results more interesting.

I tend to agree. For most of the loci there are multiple potential genes implicated and each of the genes are involved in multiple pathways. You could perhaps argue that there are more genes involved in the immune and nervous system than expected. But it's hard to say how many immune-related...

Yes look like you're right. It seems that they highlight the GLMNET lasso model because it did well on the test set (while selection of the model should have happened before that).

I think platelet-derived cfRNA was decreased in ME/CFS. EDIT: so that would mean that the platelets are less likely to rupture in ME/CFS?

The model that reached the best fit (in the 30% test samples) was GLMNET Lasso. It reached a maximum accuracy of 77% (84% sensitivity, and 68% specificity, testing AUC-ROC: 0.81 (95% CI: [0.694 to 0.926]). This is similar to BiomapAI which reported an accuracy of 72.5% and AUC of 0.82 (but...

They also found that in their machine learning models, the accuracy was highly variable depending on the predictors that were included. The main reason for this was thee fraction of platelet-derived cfRNA, which was apparently lower in ME/CFS patients compared to controls. Not sure what this...

They tested RNA outside of the cell which represents a mixture of RNA fragments released from many different cell types all over the body. Perhaps one of the more interesting findings is that they found no differences in Viral RNA Signatures between ME/CFS patients and controls. In the theory...

I suppose they did all that selecting in the 70% training set and then tested it in the 30% data that the model hadn't seen yet.

They give the example of HMGCR, an enzyme involved in cholesterol synthesis. Variants in the HMGCR gene identified by GWAS have only a small effect (I've read SNPs had an OR ≥ 0.9). However, drugs such as statins, which inhibit HMGCR, produce large reductions in cholesterol land cardiovascular...

RS stands for the relative probability of success (expressed relative to drug targets without genetic support). The authors extracted data on drug development from Citeline Pharmaprojects for monotherapy programmes added since 2000. The interesting figure is 1D. showing that RS is not...

Chris Ponting pointed to this study following the publication of DecodeME to argue that small effect size in SNPs do not indicate what the potential effect of a drug would be...

I'd also be interested in the full text if someone has acces.

I've been trying to understand this through a made-up analogy. Thought I might share it to see if it holds and if others find it useful or not. Suppose an illness is caused by a structure somewhere in the body that lets cells through that it should hold back, like a dam that is breaking. There...

It's not really important so no problem if they don't find the time to look at this. It's probably because I don't have any experience with GWAS that I don't fully understand.

This might warrant its own thread because it has a lot of info and advice that is not available in other formats. I made this thread about it on social media: 1) There's a new document with care advice for patients with (very) severe ME/CFS. It was published by the Austrian Society for...